EBV nuclear antigen (EBNA). You develop antibodies to EBNA 2 to 4 months after infection, and they last for the rest of your life. They are not present during the acute phase of infection.

EBV nuclear antigen (EBNA). This tests for antibodies to EBNA. These antibodies will be seen if you've been infected by EBV for more than two to four months.

These components, which are not present during periods of dormancy or chronic disease, can be measured. In particular, the EBV viral capsid antigen EBV VCA IgM is present in the early stages of EBV ...

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci U S A 1997;94:12616-12621.

Most residents of Taiwan are first infected with EBV in early childhood, and IgG antibodies against EBV capsid antigen persist for at least decades and probably for life. 8 IgG antibodies are ...

Five new recombinant Epstein-Barr Virus (EBV) antigens have been added to a repertoire of broad offering of products for in-vitro diagnostic manufacturing and research applications. The EBV Capsid ...

Epstein-Barr virus (EBV) is a human gamma herpesvirus that transforms B-cell growth with the potential to induce malignancies. EBV reactivation and post-transplantation lymphoproliferative disease ...

Repeat or reactivated Epstein-Barr virus infection is associated with development of lupus in African Americans and older whites, and the association is influenced by a variation in the gene for ...

Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma Story by PR Newswire • 4mo ...